Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: WVE) | Delayed: 3.40 -0.02 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.42 | 52 Week High | $38.50 | |||
| Open | $3.42 | 52 Week Low | $8.95 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.35 | EPS | $0.00 | |||
| Volume | 898,885 | |||||
| (NASDAQ: WVE) | Delayed: 3.40 -0.02 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.42 | 52 Week High | $38.50 | |||
| Open | $3.42 | 52 Week Low | $8.95 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.35 | EPS | $0.00 | |||
| Volume | 898,885 | |||||
